Work

A phase I clinical trial of radiation therapy, durvalumab and tremelimumab in recurrent gynecologic cancer

Year: 2025

Type: article

Study design: Clinical Trial

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2025.04.006

Authors: Kelly J. Fitzgerald, Panagiotis Konstantinopoulos, Ursula Matulonis, Joyce Liu, Neil Horowitz, Elizabeth Lee, David L. Kolin, Larissa Lee, Martin King

Institution: Dana-Farber Brigham Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: AstraZeneca United States, AstraZeneca

OpenAlex ID: W4409728683

FWCI: 1.232

Cites: 16

Cited by: 3

Related to: 10